Adverum Biotechnologies's total assets for Q3 2025 were $72.40M, a decrease of ― from the previous quarter. ADVM total liabilities were $128.05M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.